Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) : KB is in IIB clinical research stage. At present, it is enrolled in more than 40 hospitals across the country

Every AI newsletter, investors ask on the investor interaction platform: is KB therapeutic drug clinically used in Hong Kong this time?

Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) . SZ) said on the investor interaction platform on April 2 that KB is in the IIb clinical research stage and is currently enrolled in more than 40 hospitals across the country.